PI
AXSM icon

PEAK6 Investments’s Axsome Therapeutics AXSM Stock Holding History

PEAK6 Investments’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,100
Closed -$623K – 3919
2023
Q1 		$623K Buy
+10,100
New +$664K ﹤0.01% 2223

Other funds holding AXSM

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PEAK6 Investments's AXSM Position: Q3 2024 in Review

PEAK6 Investments opened a new position in Axsome Therapeutics (AXSM) in Q3 2024: 3,760 shares worth $338K. The stake represents ﹤0.01% of the portfolio and ranks #2531 among its holdings. This is a return to the name: PEAK6 Investments previously reported a position in AXSM as recently as Q1 2024.

PEAK6 Investments first reported a position in AXSM in Q4 2023 and has held it in 3 quarters since. 278 funds tracked by Wall St. Rank hold AXSM as of Q3 2024.

  • PEAK6 Investments held 3,760 shares of Axsome Therapeutics worth $338K as of Q3 2024.
  • Axsome Therapeutics was a new PEAK6 Investments position in Q3 2024.
  • Axsome Therapeutics made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2531 holding.
  • PEAK6 Investments first reported a position in Axsome Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • 278 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.